Results 201 to 210 of about 535,193 (240)

Exploratory Analysis of Factors Associated With the Recovery of Erectile Dysfunction After Rectal Cancer Surgery (Sub‐Analysis of LANDMARC Trial)

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1623-1630, September 2026.
ABSTRACT Background Erectile dysfunction (ErD) is an important complication after rectal cancer surgery, however a substantial proportion of patients experience functional recovery over time. Evidence regarding which patients are more likely to recover remains limited.
Ryosuke Mizuno, Koya Hida, Masakatsu Numata, Takashi Sakamoto, Kazutaka Obama, Akio Shiomi, Ryo Inada, Manabu Shiozawa, Mayumi Ozawa, Masanori Hotchi, Daisuke Yamamoto, Suguru Hasegawa, Masashi Miguchi, Shinobu Ohnuma, Tomohiro Yamaguchi, Tomonori Akagi, Yusuke Kinugasa, Shigeki Yamaguchi, Hiroyasu Kagawa, Masahiko Watanabe, Takeshi Naitoh, Ichiro Takemasa   +21 more
wiley   +1 more source

Low diagnostic yield of routine preoperative chest CT in patients undergoing partial nephrectomy: A national cohort study using UroCCR data (UroCCR n°216)

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objective The aim of this study was to evaluate the diagnostic yield and downstream clinical impact of routine preoperative chest CT in patients undergoing partial nephrectomy (PN) for localized renal cell carcinoma. Methods We conducted a retrospective multicentre study using data from the French Urological Cancer Comprehensive Cohort (UroCCR)
Ali Bourgi, Gaëlle Margue, Pierre Bigot, Norbert De Brek, Louis Surlemont, Martin Lorette, Nicolas Branger, Thomas Prudhomme, Aurélien Adypagavane, Véra Chatain, Thibaut Waeckel, Alexis Fontenil, Victor Gaillard, Jean‐Jacques Patard, Constance Michel, Julien Guillotreau, Olivier Belas, Maxime Vallée, Stéphane De Vergie, Jean‐Baptiste Beauval, Clément Sarrazin, Benjamin Delattre, Frédéric Panthier, Lionel Hoquetis, Romain Boissier, Julien Anract, Marie Chicaud, Alexandre Marsaud, Richard Mallet, Quentin‐Côme Le Cerlc, Khalil Chalhoub, Idir Ouzaid, Jean‐Christophe Bernhard, Franck Bruyère   +33 more
wiley   +1 more source

Salvage prostate therapies for local pelvic recurrence after primary radiation for prostate cancer

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objectives The purpose of this study is to evaluate salvage treatment after primary radiation therapy (RT) for prostate cancer within our hospital system. Specifically, we aim to evaluate treatment patterns, oncologic outcomes and complications.
Jamie Michael, Kathryn Fink, Vivian Wan, Sai K. S. R. Kaushik, Clayton Neill, Yutai Li, Ridwan Alam, David J. VanderWeele, Shilajit Kundu, Ashley E. Ross   +9 more
wiley   +1 more source

Lower trust in artificial intelligence than physicians coexists with high willingness to engage in artificial intelligence‐assisted prostate cancer management among active surveillance patients

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objectives This study aimed to examine the sentiment for artificial intelligence (AI) among prostate cancer (PCa) patients on active surveillance (AS) and to evaluate how that sentiment relates to patient willingness to engage with AI. Materials and Methods We conducted a 23‐question online survey (November–December 2025) distributed through ...
Eric S. Chai, Kaitlynn Abraham, Riley Hanes, Adam Williams, Howard Wolinsky, Oleksandr N. Kryvenko, Radka Stoyanova, Frank J. Penedo, Archan Khandekar, Bruno Nahar, Mark L. Gonzalgo, Dipen J. Parekh, Sanoj Punnen   +12 more
wiley   +1 more source

Endoscopic management of upper tract urothelial carcinoma with laser ablation including Magneto pulse modulation

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objective This study aimed to assess the efficacy and safety of different laser technologies, including the new Holmium:YAG (Ho:YAG) Magneto pulse modulation, for the endoscopic ablation of upper tract urothelial carcinoma (UTUC). Materials and methods Sixty‐eight patients with UTUC from two centres were treated between February 2022 and June ...
Davide Perri, Luis Rico, Giorgio Bozzini, Pablo Contreras   +3 more
wiley   +1 more source

Perioperative propranolol during robotic‐assisted radical prostatectomy: A randomised, double‐blind, placebo‐controlled, pilot trial (PeP‐RALP)

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objective This study aimed to determine the feasibility and safety of administering perioperative propranolol, as an adjunct to reduce prostate cancer recurrence, in patients undergoing robotic‐assisted laparoscopic prostatectomy (RALP) for European Association of Urology (EAU) intermediate‐ or high‐risk prostate cancer.
Shivanthe Sivanesan, Håkon Ramberg, Thomas Kristiansen, Suraj B. Thapa, Marthe Bjøre, Viktor Berge, Fredrik Ottosson, Bjørn Brennhovd, Anne M. H. Storås, Per M. Thorsby, Sandra R. Dahl, Alfonso Urbanucci, Helene Hartvedt Grytli, Lars Bjerke, Kristin Austlid Taskén   +14 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Erectile Dysfunction

Nursing Standard, 2008
Erectile dysfunction is a common problem affecting sexual function in men. Approximately one in 10 men over the age of 40 is affected by this condition and the incidence is age related. Erectile dysfunction is a sentinel marker for several reversible conditions including peripheral and coronary vascular disease, hypertension and diabetes mellitus ...
openaire   +4 more sources

Causes of Erectile Dysfunction

Endocrine, 2004
Erectile dysfunction (ED) arises as a result of a collision of circumstances among any of a number of factors (e.g., risk factors, causes, probable associations), each with its own primary power to affect the outcome. Furthermore, each of the components has its own timing as part of a complex effort of compensation and adjustment that often obscures ...
Jeremy P W, Heaton, Michael A, Adams
openaire   +2 more sources

Hypertension and Erectile Dysfunction

High Blood Pressure & Cardiovascular Prevention, 2006
Erectile dysfunction (ED) is frequently reported by hypertensive patients. The prevalence increases from 30% at the age of 50 years to 50% or more in patients aged over 70 years, i.e. 2-fold higher than that observed in normotensive subjects of the same age. The conventional view holds that ED is an adverse effect of the antihypertensive treatment, but
B. Gidaro, C. Lonati, GARAGIOLA, MARIA, E. Periti, A. Morganti   +4 more
openaire   +1 more source

Pharmacotherapy for erectile dysfunction

Trends in Pharmacological Sciences, 2000
Erectile dysfunction (ED) is defined as the consistent inability to obtain or maintain an erection for satisfactory sexual relations. An estimated 20-30 million men suffer from some degree of sexual dysfunction. The past 20 years of research on erectile physiology have increased our understanding of the biochemical factors and intracellular mechanisms ...
T J, Bivalacqua, H C, Champion, W J, Hellstrom, P J, Kadowitz   +3 more
openaire   +2 more sources